Also trades as: SBFM (NASDAQ) · $vol 1M
SBFMW NASDAQ
Sunshine Biopharma, Inc.
1W: -19.0%
1M: -22.1%
3M: -70.5%
YTD: -85.5%
1Y: -88.6%
3Y: -94.7%
$0.03
-0.03 (-52.10%)
Weekly Expected Move ±71.6%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships6
As Filer
counterparties named
1
As Counterparty
mentioned by others
2
Rel. Types
2022-02-17
Earliest Filing
2026-01-05
Latest Filing
partner: 5
target: 1
Counterparties (Filed by SBFMW)
6 relationshipsCompanies named in SBFMW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Aegis Capital Corp. | — | partner | Underwriter for the firm commitment public offering of Units and warrants. | 2024-02-15 | View |
| Aegis Capital Corp. | — | partner | Acted as placement agent for the private placement of common stock and warrants. | 2023-05-16 | View |
| University of Arizona | — | partner | Sunshine Biopharma entered into an exclusive patent license agreement for SARS-CoV-2 protease inhibitors. | 2023-02-28 | View |
| Sir Mortimer B. Davis Jewish General Hospital | — | partner | Research agreement for Adva-27a anticancer compound development and IND-enabling studies | 2023-02-10 | View |
| Nora Pharma Inc. | — | target | Acquired by Sunshine Biopharma, Inc. for $30M CAD in cash, stock, and earn-out. | 2022-10-20 | View |
| Equiniti Trust Company | — | partner | Warrant agent appointed to issue the Warrants | 2022-02-17 | View |
Mentioned As Counterparty
1 mentionsOther companies that named SBFMW in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-16 | Shareholder Vote | View | |
| 2026-09-11 | Other Events | View | |
| 2026-08-28 | Officer/Director Change | View | |
| 2026-08-03 | Other Events | View | |
| 2026-07-20 | Material Agreement; Exhibits | Agreement | View |
| 2026-07-10 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-29 | Shareholder Vote | View | |
| 2026-05-19 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-04-09 | Earnings Release; Exhibits | View | |
| 2026-03-09 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2026-02-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-09-30 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-05-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-03 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-04-02 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-12-10 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR